Transcutaneous monitoring (TCM) is a non-invasive method for patients who need continuous monitoring of oxygen and carbon dioxide with minimal blood draws. Radiometer provides a complete range of transcutaneous monitoring systems, which cover parameters such as tcpO2, tcpCO2 as well as Masimo SET® SpO2 and pulse rate.

Market Analysis and Insights: Global Percutaneous Monitor Device Market
The global Percutaneous Monitor Device market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.

Global Percutaneous Monitor Device Scope and Market Size
Percutaneous Monitor Device market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Percutaneous Monitor Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Wound-healing Monitor
Baby Monitor
Other

Segment by Application
Specialty clinics
Diagnostic centers
Adult and pediatric intensive care units
Hospitals
Ambulatory surgical centers
Other

By Company
Radiometer Medical
Perimed AB
Philips
Sentec
Medicap
Humares

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia